Framework Review

Framework: the rare telehealth brand that names its 503B pharmacy

Most direct-to-consumer GLP-1 startups keep their pharmacy a secret and lean on a low headline number to win you over. Framework (the site is yourframework.com) does the cheap-number thing too — it advertises compounded semaglutide and tirzepatide for as little as a quarter of a hundred dollars a week, which works out to roughly $100 a month with no membership fee on top. But the genuinely unusual thing here is that it tells you who actually makes the medicine: The Pharmacy Hub, an FDA-registered 503B outsourcing facility. That one disclosure is what separates Framework from the pack, and it's the lens this review looks through.

Why the 503B detail actually matters to you

Compounded GLP-1s can be made two ways. The common one for telehealth is 503A — a pharmacy mixing a batch for a specific named patient, with lighter federal oversight. The other is 503B, an outsourcing facility that registers with the FDA, gets inspected like a manufacturer, and follows stricter quality-control rules. Framework says its partner, The Pharmacy Hub, runs on the 503B pathway. In plain terms: the place making your shots is held to a higher manufacturing standard than the patient-by-patient model most competitors quietly use. Framework is one of the only providers in our directory that both names the pharmacy and points to that registration, and for a product where you're injecting yourself weekly, knowing the source is not a small thing.

How the pricing really works

Framework's pitch is one clear price with zero membership fees, and the medication is included in what you pay. The advertised rate is a starting tier — the "as low as" language matters. The site shows the entry price of about $100 a month but does not publish a full per-dose ladder, so what you pay as your dose climbs over the months isn't spelled out up front. That's normal for compounded programs (higher doses usually cost more), but it means the headline isn't a guaranteed flat rate. Even so, the entry point is aggressive: it sits well below our category median of $170 a month, and because there's no separate membership charge, you're not stacking a recurring fee on top of the drug.

• What's included: the compounded medication itself, plus dietitian support and clinician check-ins
• Membership fee: none — that's a real cost saving versus programs that bill a monthly platform charge on top of the drug
• The catch: only the starting tier is published, so confirm your actual price at the dose you'll be taking before you commit

The medications and how you get them

You're choosing between compounded semaglutide (the molecule in Ozempic and Wegovy) and compounded tirzepatide (the one in Mounjaro and Zepbound). These are not brand-name pens — they're compounded versions, and Framework is upfront about what that means. To its credit, the site publishes the full FDA disclaimer in plain sight: these formulations aren't FDA-approved and haven't been through clinical trials for safety, efficacy, or equivalence to the approved drugs. That honesty is a good sign. Framework says U.S.-licensed clinicians guide the selection between the two drugs rather than letting you just pick off a menu, which fits its "personalized plan" positioning.

What Framework doesn't tell you

For all the things Framework gets right, there's a real list of blanks — and you should weigh them honestly. The homepage doesn't show a LegitScript certification, which is the badge serious telehealth pharmacies usually display. It doesn't list which states it serves, so you can't confirm coverage where you live without contacting them. There's no named medical director or clinical leadership, no corporate legal entity in the footer (no LLC or Inc. to identify who you're actually doing business with), and no published refund, cancellation, or arbitration terms. None of these are deal-breakers on their own, but together they're why our editors rate verification confidence as medium rather than high. The pharmacy disclosure is strong; the corporate and regulatory transparency around it is thin.

Who should choose Framework — and who shouldn't

Framework is a good fit if your priority is a low monthly cost from a provider that's willing to name its pharmacy and point to a higher-grade 503B manufacturing pathway. If you've been comparing programs and you care more about where the medicine comes from than about brand-name pens, this is one of the cheaper credible options to look at.

Skip it if you need certainty before you sign up. If you want to confirm your state is covered, see a published refund policy, know the name of the medical director overseeing your care, or get an exact price for the higher dose you'll eventually reach, Framework doesn't put those answers on the page. Anyone who wants brand-name Wegovy or Zepbound should also look elsewhere — this is a compounded-only program.

Getting your questions answered

One practical plus: Framework publishes a toll-free phone line, (888) 412-0666, plus an email at support@yourframework.com. Before you pay, use the phone number to confirm three things the site leaves out — whether they ship to your state, what the price becomes at higher doses, and what happens if you want to cancel. A provider that answers those clearly over the phone earns a lot more trust than the homepage alone gives.

Bottom line

Framework punches above its weight on the two things that are hardest to fake: a named, FDA-registered 503B pharmacy partner and a visible, honest FDA disclaimer, all wrapped in a genuinely low $100-a-month starting price with no membership fee. Those are real, verifiable strengths. The weakness is everything around them — no disclosed states, no LegitScript, no named clinical leadership, no corporate entity, no posted refund terms. If transparency about the pharmacy is what you weight most, Framework is one of the better-value picks in this directory. If you need the full paperwork before trusting a telehealth brand, call them first and get the gaps filled in before you commit. You can see how we weigh these signals in our scoring methodology.

For a side-by-side, bmiMD ($99/month) is a comparable option to weigh against Framework.